Citadel Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$929K Buy
+4,200
New +$1.03M ﹤0.01% 7821
2025
Q4
Sell
-1,300
Closed -$322K 14018
2025
Q3
$322K Sell
1,300
-8,100
-86% -$1.94M ﹤0.01% 10198
2025
Q2
$2.26M Buy
9,400
+6,800
+262% +$1.58M ﹤0.01% 5477
2025
Q1
$589K Buy
2,600
+1,900
+271% +$418K ﹤0.01% 8116
2024
Q4
$144K Hold
700
﹤0.01% 10956
2024
Q3
$170K Sell
700
-4,300
-86% -$1.01M ﹤0.01% 10391
2024
Q2
$1.1M Buy
5,000
+2,100
+72% +$456K ﹤0.01% 6400
2024
Q1
$652K Buy
2,900
+1,600
+123% +$361K ﹤0.01% 7807
2023
Q4
$286K Sell
1,300
-3,200
-71% -$677K ﹤0.01% 9269
2023
Q3
$987K Sell
4,500
-1,200
-21% -$271K ﹤0.01% 6569
2023
Q2
$1.28M Buy
5,700
+4,300
+307% +$860K ﹤0.01% 5952
2023
Q1
$268K Sell
1,400
-1,500
-52% -$290K ﹤0.01% 9605
2022
Q4
$536K Sell
2,900
-19,100
-87% -$3.36M ﹤0.01% 8098
2022
Q3
$3.66M Buy
22,000
+13,600
+162% +$2.77M ﹤0.01% 4416
2022
Q2
$1.73M Sell
8,400
-12,400
-60% -$2.8M ﹤0.01% 5836
2022
Q1
$5.03M Buy
20,800
+13,200
+174% +$3.06M ﹤0.01% 4166
2021
Q4
$1.85M Buy
7,600
+4,300
+130% +$982K ﹤0.01% 6429
2021
Q3
$674K Sell
3,300
-7,400
-69% -$1.58M ﹤0.01% 9164
2021
Q2
$2.21M Buy
10,700
+6,900
+182% +$1.39M ﹤0.01% 6342
2021
Q1
$724K Buy
3,800
+500
+15% +$92.8K ﹤0.01% 8869
2020
Q4
$625K Sell
3,300
-800
-20% -$149K ﹤0.01% 7731
2020
Q3
$722K Sell
4,100
-1,400
-25% -$224K ﹤0.01% 6628
2020
Q2
$844K Buy
+5,500
New +$838K ﹤0.01% 6147
2020
Q1
Sell
-13,800
Closed -$2.1M 10146
2019
Q4
$2.1M Sell
13,800
-1,400
-9% -$205K ﹤0.01% 4343
2019
Q3
$2.2M Buy
15,200
+10,100
+198% +$1.51M ﹤0.01% 4339
2019
Q2
$759K Sell
5,100
-3,500
-41% -$468K ﹤0.01% 6152
2019
Q1
$1.1M Buy
8,600
+2,100
+32% +$247K ﹤0.01% 5414
2018
Q4
$695K Buy
6,500
+2,800
+76% +$313K ﹤0.01% 5889
2018
Q3
$423K Buy
3,700
+1,500
+68% +$170K ﹤0.01% 6969
2018
Q2
$231K Sell
2,200
-2,500
-53% -$251K ﹤0.01% 7641
2018
Q1
$439K Buy
+4,700
New +$427K ﹤0.01% 6118
2017
Q4
Sell
-15,000
Closed -$1.33M 8422
2017
Q3
$1.33M Sell
15,000
-8,000
-35% -$678K ﹤0.01% 3928
2017
Q2
$1.88M Buy
23,000
+11,000
+92% +$836K ﹤0.01% 3249
2017
Q1
$834K Buy
12,000
+4,300
+56% +$298K ﹤0.01% 4264
2016
Q4
$519K Buy
+7,700
New +$522K ﹤0.01% 4841
2016
Q1
Sell
-2,400
Closed -$181K 7892
2015
Q4
$181K Sell
2,400
-16,400
-87% -$1.18M ﹤0.01% 5933
2015
Q3
$1.22M Buy
18,800
+9,900
+111% +$654K ﹤0.01% 3559
2015
Q2
$574K Buy
8,900
+700
+9% +$47.2K ﹤0.01% 4748
2015
Q1
$576K Sell
8,200
-3,600
-31% -$238K ﹤0.01% 4701
2014
Q4
$765K Buy
+11,800
New +$729K ﹤0.01% 4122
2014
Q3
Sell
-1,400
Closed -$75K 8388
2014
Q2
$75K Buy
+1,400
New +$72.1K ﹤0.01% 6456
2014
Q1
Sell
-900
Closed -$43K 8004
2013
Q4
$43K Hold
900
﹤0.01% 6130
2013
Q3
$39K Sell
900
-100
-10% -$4.34K ﹤0.01% 5922
2013
Q2
$43K Buy
+1,000
New +$43K ﹤0.01% 5739

Other funds holding STE

Citadel Advisors's STE Position: Q1 2026 in Review

Citadel Advisors reduced its Steris (STE) stake by 65% in Q1 2026, selling an estimated $50.5M and leaving 109,867 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Citadel Advisors first reported a position in STE in Q2 2013 and has held it in 50 quarters since. The position peaked at $80.2M in Q4 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Citadel Advisors held 109,867 shares of Steris worth $24.3M as of Q1 2026.
  • Citadel Advisors sold 206,401 Steris shares in Q1 2026, an estimated $50.5M.
  • Steris made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2095 holding.
  • Citadel Advisors first reported a position in Steris in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Steris position peaked at $80.2M in Q4 2025.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.